Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 360,519 | 272,551 | 164,677 | 211,007 | 178,875 |
| Cost of Goods | 19,921 | 28,028 | 6,950 | 15,781 | 11,420 |
| Gross Profit | 340,598 | 244,523 | 157,727 | 195,226 | 167,455 |
| Operating Expenses | 192,542 | 199,592 | 230,026 | 192,991 | 202,832 |
| Operating Income | 148,977 | 44,959 | -71,349 | 3,016 | -34,957 |
| Interest Expense | 48,481 | 49,030 | 55,188 | 32,592 | 30,358 |
| Other Income | -2,951 | 1,609 | -12,546 | 6,502 | -5,737 |
| Pre-tax Income | 97,545 | -2,462 | -139,083 | -23,074 | -71,052 |
| Income Tax | 14,049 | 347 | -4,118 | -38,970 | -6,203 |
| Net Income Continuous | 83,496 | -2,809 | -134,965 | 15,896 | -64,849 |
| Net Income | $83,496 | $-2,809 | $-134,965 | $15,896 | $-64,849 |
| EPS Basic Total Ops | 1.01 | -0.03 | -1.88 | 0.20 | -0.83 |
| EPS Basic Continuous Ops | 1.01 | -0.03 | -1.88 | 0.20 | -0.83 |
| EPS Diluted Total Ops | 0.92 | -0.03 | -1.63 | 0.20 | -0.83 |
| EPS Diluted Continuous Ops | 0.91 | -0.03 | -1.65 | 0.18 | -0.83 |
| EPS Diluted Before Non-Recurring Items | 0.92 | -0.03 | -1.67 | 0.20 | -0.83 |
| EBITDA(a) | $160,152 | $57,490 | $-63,184 | $8,327 | $-31,705 |